Abstract
Multiplex families with a high prevalence of a psychiatric disorder are often examined to identify rare genetic variants with large effect sizes. In the present study, we analysed whether the risk for bipolar disorder (BD) in BD multiplex families is influenced by common genetic variants. Furthermore, we investigated whether this risk is conferred mainly by BD-specific risk variants or by variants also associated with the susceptibility to schizophrenia or major depression. In total, 395 individuals from 33 Andalusian BD multiplex families (166 BD, 78 major depressive disorder, 151 unaffected) as well as 438 subjects from an independent, BD case/control cohort (161 unrelated BD, 277 unrelated controls) were analysed. Polygenic risk scores (PRS) for BD, schizophrenia (SCZ), and major depression were calculated and compared between the cohorts. Both the familial BD cases and unaffected family members had higher PRS for all three psychiatric disorders than the independent controls, with BD and SCZ being significant after correction for multiple testing, suggesting a high baseline risk for several psychiatric disorders in the families. Moreover, familial BD cases showed significantly higher BD PRS than unaffected family members and unrelated BD cases. A plausible hypothesis is that, in multiplex families with a general increase in risk for psychiatric disease, BD development is attributable to a high burden of common variants that confer a specific risk for BD. The present analyses demonstrated that common genetic risk variants for psychiatric disorders are likely to contribute to the high incidence of affective psychiatric disorders in the multiplex families. However, the PRS explained only part of the observed phenotypic variance, and rare variants might have also contributed to disease development.
Original language | English |
---|---|
Pages (from-to) | 1286-1298 |
Number of pages | 13 |
Journal | Molecular Psychiatry |
Volume | 26 |
Issue number | 4 |
Early online date | 11 Nov 2019 |
DOIs | |
Publication status | Published - Apr 2021 |
Funding
Acknowledgements The study was supported by the German Federal Ministry of Education and Research (BMBF), through the Integrated Network IntegraMent, under the auspices of the e:Med programme (grants 01ZX1314A to MMN and SC; 01ZX1314G to MR; 01ZX1614J to BMM) through grants 01EE1406C to MR and 01EE1409C to MR and SHW, and through ERA-NET NEURON, “SynSchiz—Linking synaptic dysfunction to disease mechanisms in schizophrenia—a multilevel investigation” (01EW1810 to MR) and BMBF grants 01EE1409C and 01EE1406C to MR and SHW; by the German Research Foundation (DFG grants FOR2107; RI908/11-2 to MR; NO246/10-2 to MMN; MU1315/8-2 to BMM; WI 3439/3-2 to SHW), by the Andalusian regional Health and Innovation Government (grants PI-0060-2017, RC-0006-2015 the Nicolas Monarde Programme for YDO and CTS-546) and by the Swiss National Science Foundation (SNSF grant 156791 to SC). MMN is a member of the DFG-funded cluster of excellence ImmunoSensation. The PGC has received major funding from the US National Institute of Mental Health and the US National Institute of Drug Abuse (U01 MH109528 and U01 MH1095320). We thank the research participants and employees of 23andMe, Inc. for their contribution to the MDD meta-analysis published in [14]. We thank the International Genomics of Alzheimer's Project (IGAP) for providing summary results data for the present analyses. See the Supplementary Data for extended Acknowledgements.
Funders | Funder number |
---|---|
Andalusian regional Health and Innovation Government | CTS-546, RC-0006-2015, PI-0060-2017 |
Deutsche Forschungsgemeinschaft | 46/10-1, RI908/11-1 |
German Federal Ministry of Education and Research | |
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung | |
US National Institute of Mental Health | |
National Institute of Mental Health | U01MH109528 |
National Institute on Drug Abuse | U01 MH1095320 |
Deutsche Forschungsgemeinschaft | NO246/10-2, FOR2107, WI 3439/3-2, MU1315/8-2, RI908/11-2 |
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung | 156791 |
Bundesministerium für Bildung und Forschung | 01EW1810, 01EE1409C, 01ZX1614J, 01ZX1314G, 01ZX1314A, 01EE1406C |
Cohort Studies
- Netherlands Twin Register (NTR)